Search Login Register

amrubicin Summary

60 relevant articles (6 outcomes, 26 trials/studies) found for this Bio-Agent

Description: structure in first source; a 9-amino-anthracycline antibiotic

Also Known As: (7S,9S)-9-acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione hydrochloride; SM 5887; SM-5887; amrubicin hydrochloride

Key Diseases for which amrubicin is Relevant

  1. Small Cell Carcinoma (Small Cell Lung Cancer) : 2 outcomes 16 studies in 30 results
  2. Neoplasms (Cancer) : 2 outcomes 1 study in 14 results
  3. Non-Hodgkin Lymphoma (Lymphosarcoma) : 1 outcome 2 studies in 2 results
  4. Lymphoma (Lymphomas) : 1 outcome 2 studies in 2 results
  5. Lung Neoplasms (Lung Cancer) : 4 studies in 11 results
Show All >>

Drugs Related to amrubicin

  1. irinotecan (Camptosar)
  2. Doxorubicin (Adriamycin)
  3. Cisplatin (Platino)
  4. Topotecan (Hycamtin)
  5. Type II DNA Topoisomerases (Topoisomerase II)
  6. amrubicinol
  7. Carboplatin (JM8)
  8. Vincristine (Oncovin)
  9. Prednisolone (Predate)
  10. Type I DNA Topoisomerases (Topoisomerase I)
Show All >>

Therapies Related to amrubicin

  1. Drug Therapy (Chemotherapy)
  2. Heterologous Transplantation (Xenotransplantation)
  3. Combination Drug Therapy (Combination Chemotherapy)
  4. Renal Dialysis (Hemodialysis)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.